HIGHLIGHTS
- who: Palanichamy Nandhini and colleagues from the Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, Department of Biology, College of Science, Al-Zulfi, Majmaah University, Majmaah, Saudi Arabia have published the Article: Recent Developments in Methicillin-Resistant Staphylococcus aureus (MRSA) Treatment: A Review, in the Journal: Antibiotics 2022, 11, 606. of /2022/
- what: As a result, S. aureus is one of the major reasons for the spread of hospital and community-acquired infections, which brings about serious consequences and life-threatening diseases. This study proposed the high-dose teicoplanin treatment . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.